95 related articles for article (PubMed ID: 3092851)
1. Effect of oral verapamil on glibenclamide stimulated insulin secretion.
Semple CG; Omile C; Buchanan KD; Beastall GH; Paterson KR
Br J Clin Pharmacol; 1986 Aug; 22(2):187-90. PubMed ID: 3092851
[TBL] [Abstract][Full Text] [Related]
2. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
El-Ouaghlidi A; Rehring E; Holst JJ; Schweizer A; Foley J; Holmes D; Nauck MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4165-71. PubMed ID: 17698900
[TBL] [Abstract][Full Text] [Related]
3. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
4. Glucose-dependent insulinotropic hormone potentiates the hypoglycemic effect of glibenclamide in healthy volunteers: evidence for an effect on insulin extraction.
Kindmark H; Pigon J; Efendic S
J Clin Endocrinol Metab; 2001 May; 86(5):2015-9. PubMed ID: 11344200
[TBL] [Abstract][Full Text] [Related]
5. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
6. Influence of oral verapamil on glucoregulatory hormones in man.
Shamoon H; Baylor P; Kambosos D; Charlap S; Plawes S; Frishman WH
J Clin Endocrinol Metab; 1985 Mar; 60(3):536-41. PubMed ID: 3882735
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
[TBL] [Abstract][Full Text] [Related]
8. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man.
Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic activity of glyburide (glibenclamide) metabolites in humans.
Rydberg T; Jönsson A; Røder M; Melander A
Diabetes Care; 1994 Sep; 17(9):1026-30. PubMed ID: 7988301
[TBL] [Abstract][Full Text] [Related]
10. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.
Hartmann D; Korn A; Komjati M; Heinz G; Haefelfinger P; Defoin R; Waldhäusl WK
Br J Clin Pharmacol; 1990 Aug; 30(2):245-52. PubMed ID: 2119677
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.
Rave K; Flesch S; Kühn-Velten WN; Hompesch BC; Heinemann L; Heise T
Diabetes Metab Res Rev; 2005; 21(5):459-64. PubMed ID: 15915547
[TBL] [Abstract][Full Text] [Related]
13. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas.
Efendić S; Enzmann F; Nylén A; Uvnäs-Wallensten K; Luft R
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5901-4. PubMed ID: 118458
[TBL] [Abstract][Full Text] [Related]
14. Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance.
De Marinis L; Mancini A; Zuppi P; Sammartano L; Valle D; Fiumara C; Sandric S; Folli G
Diabetes Res; 1992 Jan; 19(1):9-16. PubMed ID: 1468187
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
[TBL] [Abstract][Full Text] [Related]
16. Effect of verapamil on glucose response to intravenous injection of glucagon and insulin in healthy subjects.
Röjdmark S; Andersson DE; Hed R; Sundblad L
Horm Metab Res; 1980 Jul; 12(7):285-90. PubMed ID: 6995247
[TBL] [Abstract][Full Text] [Related]
17. [Clinical investigations of the effect of tolbutamide and glibenclamide on pancreatic glucagon secretion (author's transl)].
Baumeister G; Wagner H; Stahl M
Klin Wochenschr; 1975 Jun; 53(12):571-4. PubMed ID: 811925
[TBL] [Abstract][Full Text] [Related]
18. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients.
Kyllästinen M; Groop L
Ann Clin Res; 1985; 17(3):100-4. PubMed ID: 3931537
[TBL] [Abstract][Full Text] [Related]
19. Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.
De Marinis L; Barbarino A
Metabolism; 1980 Jul; 29(7):599-604. PubMed ID: 6247604
[TBL] [Abstract][Full Text] [Related]
20. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
Gudat U; Bungert S; Kemmer F; Heinemann L
Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
